Summaries & Associations of Study Results
TR-473 Theophylline
Target Organs and Levels of Evidence
NTP Technical Report Number 473
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| THEOPHYLLINE 58-55-9 |
12/11/96 | DIURETIC, CARDIAC STIMULANT, SMOOTH MUSCLE RELAXANT, ANTIASTHMATIC, OCCURS NATURALLY IN TEA (MERCK 1989) | Gavage R: 7.5, 25, OR 75 MG/KG; 50/GROUP FM: 7.5, 25, OR 75 MG/KG; 50/GROUP MM: 15, 50, OR 150 MG/KG; 50/GROUP | Southern Research Institute |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | MESENTERIC ARTERY: CHRONIC INFLAMMATION | |||
| FR: NO EVIDENCE | ||||
| MM: NO EVIDENCE | ||||
| FM: NO EVIDENCE | ||||
Web page last updated on February 10, 2006
